MET inhibition radiosensitizes KRAS-mutant rectal cancer.

被引：0
|
作者：
D'Ambrosio, Antonio [1 ]
Verginelli, Federica [1 ]
Orzan, Francesca [1 ]
Albano, Raffaella [1 ]
Casanova, Elena [1 ]
Luraghi, Paolo [1 ]
De Bacco, Francesca [1 ]
Bertotti, Andrea [2 ]
Trusolino, Livio [2 ]
Senetta, Rebecca [3 ]
Sapino, Anna [3 ]
Del Mastro, Elena [4 ]
Gatti, Marco [4 ]
Comoglio, Paolo M. [5 ]
Boccaccio, Carla [1 ]
机构：
[1] IRCCS Candiolo Canc Inst, Lab Canc Stem Cell Res FPO, Candiolo, Italy
[2] IRCCS Candiolo Canc Inst, Lab Translat Canc Med FPO, Candiolo, Italy
[3] IRCCS Candiolo Canc Inst, Unit Pathol FPO, Candiolo, Italy
[4] IRCCS Candiolo Canc Inst, Unit Radiotherapy FPO, Candiolo, Italy
[5] IRCCS Candiolo Canc Inst, Lab Exploratory Res & Mol Canc Therapy FPO, Candiolo, Italy
来源：
CANCER RESEARCH | 2021年 / 81卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1387
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Methionine restriction radiosensitizes KRAS mutant rectal cancer
    Wolfe, Adam R.
    Garg, Sarita
    Van Matre, Stetson
    Eluvathingal, Robin
    Zuniga, Oscar
    Rodrigues, Henrique
    Aykin-Burns, Nukhet
    Miousse, Isabelle Racine
    CANCER RESEARCH, 2023, 83 (07)
  • [2] ERK MAPK inhibition enhances the immunogenicity of KRAS-mutant colorectal cancer.
    Ryan, Meagan B.
    de la Cruz, Ferran Fece
    Ahronian, Leanne G.
    Phat, Sarah
    Myers, David T.
    Shahzade, Heather A.
    Hong, Catriona
    Corcoran, Ryan B.
    MOLECULAR CANCER RESEARCH, 2020, 18 (05) : 76 - 76
  • [3] Combination inhibitor strategies targeting KRAS effector signaling in KRAS-mutant pancreatic cancer.
    Ozkan-Dagliyan, Irem
    Goodwin, Craig M.
    Bryant, Kirsten L.
    George, Samuel D.
    Lucas, Kelly
    Gautam, Prson
    Wennerberg, Krister
    Cox, Adrienne D.
    Der, Channing J.
    MOLECULAR CANCER RESEARCH, 2020, 18 (05) : 68 - 68
  • [4] Combined MEK and mitophagy inhibition promotes mtDNA-mediated innate immunity in KRAS-mutant cancer.
    Tanaka, Kosuke
    Morita, Tomoko Yamamori
    Hakozaki, Yumi
    Yoshiya, Miyuki
    Mashima, Chiaki
    Liu, Jie
    Kageyama, Shun-Ichiro
    Ohashi, Akihiro
    Kobayashi, Susumu
    CANCER RESEARCH, 2022, 82 (12)
  • [5] Dual inhibition of VEGF and PARP suppresses KRAS-mutant colorectal cancer
    Zhong, Longhui
    Wang, Rong
    Wang, Yanxia
    Peng, Shunli
    Ma, Yueyun
    Ding, Sijie
    Yang, Hong
    Chen, Shiyu
    Luo, Xiaoqing
    Wang, Wei
    NEOPLASIA, 2020, 22 (09): : 365 - 375
  • [6] Suppression of KRas-mutant cancer through the combined inhibition of KRAS with PLK1 and ROCK
    Jieqiong Wang
    Kewen Hu
    Jiawei Guo
    Feixiong Cheng
    Jing Lv
    Wenhao Jiang
    Weiqiang Lu
    Jinsong Liu
    Xiufeng Pang
    Mingyao Liu
    Nature Communications, 7
  • [7] Suppression of KRas-mutant cancer through the combined inhibition of KRAS with PLK1 and ROCK
    Wang, Jieqiong
    Hu, Kewen
    Guo, Jiawei
    Cheng, Feixiong
    Lv, Jing
    Jiang, Wenhao
    Lu, Weiqiang
    Liu, Jinsong
    Pang, Xiufeng
    Liu, Mingyao
    NATURE COMMUNICATIONS, 2016, 7
  • [8] Closing the door on KRAS-mutant lung cancer
    Cully, Megan
    NATURE REVIEWS DRUG DISCOVERY, 2016, 15 (11) : 747 - 747
  • [9] Closing the door on KRAS-mutant lung cancer
    Megan Cully
    Nature Reviews Drug Discovery, 2016, 15 : 747 - 747
  • [10] Current therapy of KRAS-mutant lung cancer
    Ghimessy, Aron
    Radeczky, Peter
    Laszlo, Viktoria
    Hegedus, Balazs
    Renyi-Vamos, Ferenc
    Fillinger, Janos
    Klepetko, Walter
    Lang, Christian
    Dome, Balazs
    Megyesfalvi, Zsolt
    CANCER AND METASTASIS REVIEWS, 2020, 39 (04) : 1159 - 1177
12345